Trials / Recruiting
RecruitingNCT06953622
Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 330 (estimated)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent foramen ovale, and search for the possible influencing factors, construct models that influence prognosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Conservative treatment | Receive no antipaletet drug treatment and surgery |
| DRUG | Antipaletet drug | Use of antipaletet drugs. |
| PROCEDURE | Patent Foramen Ovale Closure | Receive the surgery of Patent Foramen Ovale |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2025-05-01
- Last updated
- 2025-05-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06953622. Inclusion in this directory is not an endorsement.